Physician profile
Allen S Wang
NPI 1891003745
$3,376.49
in general payments reported to CMS, 2019-2025
18 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $196 · 2021: $416 · 2022: $667 · 2023: $1,027 · 2024: $241 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $620.23 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Rxsight INC | $416.32 | 2021-2023 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal) |
| Sun Pharmaceutical Industries INC. | $411.99 | 2020-2023 | Cequa |
| Bausch & Lomb Americas INC. | $297.00 | 2022-2025 | Miebo, Vyzulta, Prolensa |
| Johnson & Johnson Surgical Vision, INC. | $288.35 | 2019-2024 | Veritas Vision System, Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $287.19 | 2019-2021 | |
| Allergan, INC. | $231.23 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $230.81 | 2019-2023 | |
| Glaukos Corporation | $229.91 | 2025 | Idosetr |
| Alcon Vision LLC | $96.42 | 2021-2025 | Tryptyr, Centurion, Hydrus Microstent |
| Carl Zeiss Meditec USA, INC. | $85.07 | 2023 | Artevo 800, Callisto Eye |
| Thea Pharma INC. | $67.14 | 2024 | Iyuzeh |
| Abbott Laboratories | $24.22 | 2023 | Amplatzer Amulet |
| Ocular Therapeutix, INC. | $19.73 | 2023 | Dextenza |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $18.03 | 2021 | |
| New World Medical,INC. | $16.95 | 2021 | |
| Harrow Eye, LLC | $16.50 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.